Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases

Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases.

Saved in:
Bibliographic Details
Main Authors: Araújo,Lorena Ulhôa, Santos,Delba Fonseca, Bodevan,Emerson Cotta, Cruz,Hellen Lilliane da, Souza,Jacqueline de, Silva-Barcellos,Neila Márcia
Format: Digital revista
Language:English
Published: Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-11692019000100398
record_format ojs
spelling oai:scielo:S0104-116920190001003982019-11-29Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseasesAraújo,Lorena UlhôaSantos,Delba FonsecaBodevan,Emerson CottaCruz,Hellen Lilliane daSouza,Jacqueline deSilva-Barcellos,Neila Márcia Pharmacoepidemiology Polypharmacy Potentially Inappropriate Medication List Primary Health Care Patient Safety Chronic Disease Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases.info:eu-repo/semantics/openAccessEscola de Enfermagem de Ribeirão Preto / Universidade de São PauloRevista Latino-Americana de Enfermagem v.27 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398en10.1590/1518-8345.3123.3217
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Araújo,Lorena Ulhôa
Santos,Delba Fonseca
Bodevan,Emerson Cotta
Cruz,Hellen Lilliane da
Souza,Jacqueline de
Silva-Barcellos,Neila Márcia
spellingShingle Araújo,Lorena Ulhôa
Santos,Delba Fonseca
Bodevan,Emerson Cotta
Cruz,Hellen Lilliane da
Souza,Jacqueline de
Silva-Barcellos,Neila Márcia
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
author_facet Araújo,Lorena Ulhôa
Santos,Delba Fonseca
Bodevan,Emerson Cotta
Cruz,Hellen Lilliane da
Souza,Jacqueline de
Silva-Barcellos,Neila Márcia
author_sort Araújo,Lorena Ulhôa
title Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
title_short Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
title_full Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
title_fullStr Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
title_full_unstemmed Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
title_sort patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
description Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases.
publisher Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398
work_keys_str_mv AT araujolorenaulhoa patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
AT santosdelbafonseca patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
AT bodevanemersoncotta patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
AT cruzhellenlillianeda patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
AT souzajacquelinede patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
AT silvabarcellosneilamarcia patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases
_version_ 1756408565683191808